These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24306340)

  • 21. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update.
    Beach SR; Celano CM; Sugrue AM; Adams C; Ackerman MJ; Noseworthy PA; Huffman JC
    Psychosomatics; 2018; 59(2):105-122. PubMed ID: 29275963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulpiride induced torsade de pointes.
    Huang BH; Hsia CP; Chen CY
    Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of sertindole on QTD and TPTE.
    Nielsen J; Andersen MP; Graff C; Kanters JK; Hardahl T; Dybbro J; Struijk JJ; Meyer JM; Toft E
    Acta Psychiatr Scand; 2010 May; 121(5):385-8. PubMed ID: 20085555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?
    Romero J; Baldinger SH; Goodman-Meza D; Engstrom K; Valencia CR; Golive A; Medrano F; Rangasamy S; Makkiya M; Fisher JD; Gross J; Krumerman A; Kim S; Garcia MJ; Di Biase L; Ferrick KJ
    J Interv Card Electrophysiol; 2016 Jan; 45(1):37-45. PubMed ID: 26589717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidences, risk factors, and clinical correlates of severe QT prolongation after the use of quetiapine or haloperidol.
    Wang CL; Wu VC; Lee CH; Wu CL; Chen HM; Huang YT; Chang SH
    Heart Rhythm; 2024 Mar; 21(3):321-328. PubMed ID: 38231170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Microvolt T-Wave Alternans in Patients With Long QT Syndrome and Its Association With Torsade de Pointes.
    Takasugi N; Goto H; Takasugi M; Verrier RL; Kuwahara T; Kubota T; Toyoshi H; Nakashima T; Kawasaki M; Nishigaki K; Minatoguchi S
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003206. PubMed ID: 26839386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Perfect Storm: Abnormal Baseline QT With Chronic Methadone Use and Serious Hypokalemia.
    Lopez OJ; Othon D; Ng-Wong YK; Sleiman J
    J Investig Med High Impact Case Rep; 2024; 12():23247096241286373. PubMed ID: 39380334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Torsades de pointes with methadone.
    Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation.
    Patel N; Veve M; Kwon S; McNutt LA; Fish D; Miller CD
    HIV Med; 2013 Sep; 14(8):463-71. PubMed ID: 23506263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
    Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
    Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medication associated long QT syndrome].
    Bruggisser M; Rätz Bravo A; Bodmer M
    Praxis (Bern 1994); 2009 Dec; 98(24):1409-15; quiz 1415. PubMed ID: 19953465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
    Krantz MJ
    J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone and affairs of the heart and of the brain.
    Stimmel B
    J Addict Dis; 2003; 22(3):1-5. PubMed ID: 14621340
    [No Abstract]   [Full Text] [Related]  

  • 34. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
    Pearson EC; Woosley RL
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Psychiatric patients and QT interval monitoring].
    Girardin F; Gaspoz JM
    Rev Med Suisse; 2007 Apr; 3(106):945-8. PubMed ID: 17575970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of QT prolongation in a population of patients with substance use disorders.
    Scott AJ; Dunlop AJ; Brown A; Sadler C; Isbister GK
    Drug Alcohol Rev; 2017 Mar; 36(2):239-244. PubMed ID: 27241860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures.
    Bass AS; Hanson LA; Jackson TA
    J Pharmacol Toxicol Methods; 2009; 60(1):51-7. PubMed ID: 19447184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Droperidol, QT prolongation, and sudden death: what is the evidence?
    Kao LW; Kirk MA; Evers SJ; Rosenfeld SH
    Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for QT prolongation associated with acute psychotropic drug overdose.
    Miura N; Saito T; Taira T; Umebachi R; Inokuchi S
    Am J Emerg Med; 2015 Feb; 33(2):142-9. PubMed ID: 25445869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ECG pearl: acquired long QT syndrome].
    Tomcsányi J; Tomcsányi K
    Orv Hetil; 2018 Sep; 159(39):1607-1610. PubMed ID: 30543125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.